California Initiative to Advance Precision Medicine Advisory Council
Meet California Precision Medicine Advisory Council.
In 2020, the Governor's Office of Planning and Research (now Governor's Office of Land Use and Climate Innovation) launched new California Precision Medicine Advisory Council to provide high-level guidance on matters relating to the CIAPM program. Members represent patient advocacy and community groups, academia, private industry, health policy, clinical providers, venture capital and philanthropy. They are experts in the areas of data science, bioinformatics, pharmacology, community engagement, medical devices, and public health. At CalHHS, the Council provides high-level guidance on matters relating to CIAPM and members are selected by CalHHS or recommended by the Legislature.
Council Members
Diana Ramos
California Surgeon General Dr. Diana E. Ramos is dedicated to improving health care quality and equity. She recently served as the Assistant Deputy Director of Chronic Disease Prevention for the California Department of Public Health. Past roles include the Director for Reproductive Health in the Los Angeles County Department of Public Health and adjunct Associate Professor at the Keck University of Southern California School of Medicine.
Her areas of expertise include health disparities, social determinants of health, preconception/interconception health, preterm birth, contraception and quality improvement in health. Dr. Ramos has written and contributed numerous articles to the obstetrics and gynecology and public health literature and has lectured in Spanish and English, locally, nationally and internationally.
Dr. Ramos received her medical degree from the University of Southern California with honors and completed her residency training in obstetrics and gynecology at Los Angeles County-University of Southern California Medical Center. She received her MBA from the UCI Paul Merage School of business with an emphasis in entrepreneurship and innovation and her master's in public health from the University of California, Los Angeles. Dr. Ramos completed her undergraduate degree, a BA in Communications, Arts & Science from the University of Southern California.
Leigh Ann Simmons
Leigh Ann Simmons, PhD, MFT, FAAHB is a nationally recognized women's health researcher, trained therapist, and health coach focused on changing how people—especially childbearing
women—are seen, heard, and treated in health care. She is a tenured Professor at the University of California, Davis - Betty Irene Moore School of Nursing, where she serves as Principal
Investigator of the School's first predoctoral T32 training program, co-directs the faculty training program in patient-oriented research, directs the Health Equity Across the Lifespan
(HEAL) Lab, and co-directs the Perinatal Origins of Disparities (POD) Center.
Dr. Simmons' work advances health equity by addressing chronic disease risk, mental health, and life-course health patterns in communities that are often dismissed or underserved.
Using community-engaged and digital approaches, she develops practical, scalable interventions that improve access to care and personalized support. Her research has been funded by
the National Institutes of Health, the Veterans Health Administration, and state and federal agencies, totaling more than $16 million in direct funds.
Beyond research, Dr. Simmons has trained hundreds of health coaches, partnered with health systems and community organizations nationwide, and served as a Congressional Fellow on the U.S.
Senate Health, Education, Labor, and Pensions Committee. She is deeply committed to translating evidence into tools that patients and healthcare systems can use to improve health outcomes.
Dr. Bradley is the Senior Health Equity Fellow with the Central Valley Community Foundation.
Dr. Elize M. Bradley is a seasoned public health and health care executive with a successful 20+ year career in health policy, and research recruitment, planning, and administration. Her broad areas of expertise include community engagement, health promotion and prevention, and equity, diversity, inclusion, and belonging within the healthcare, academic, philanthropic, and community-based sectors. She is currently the Hewlett Packard Senior Health Equity Fellow for the Central Valley Community Foundation.
She previously served as the Regional Managing Director and HIPAA Privacy Officer for Kaiser Permanente's (KP) Division of Research, where she had primary responsibility for all research operations for Northern California. While at KP, she created and managed the Community Advisory Panel, as well as the Ethics Advisory Panel, for the Kaiser Permanente Research Biobank. With more than 400,000 participants, KP's Biobank is one of the largest biobanks in the United States, and was designed to advance precision medicine, medical research, and translational research. Prior to her 15 years with Kaiser Permanente, Dr. Bradley served as Senior Program Officer for The Robert Johnson Foundation (RWJF).
Dr. Bradley holds a DrPH in Health Policy and Management from the University of California, Berkeley, a J.D. from the University of California, Los Angeles, and a B.A. in Sociology (High Honors) from Williams College.
Dr. Debra Cooper received her undergraduate degree in psychology from Duke University and her PhD in Neuroscience from Emory University. Her graduate research focused on studying treatments for drug addiction. After receiving her doctorate, she continued doing research in drug addiction as a postdoctoral fellow at the University of Texas Medical Branch at Galveston.
In 2014, Dr. Cooper was selected to serve as a Policy Fellow for the California Council on Science and Technology (CCST), where she was placed in the California State Senate Office of Research. She continued working in the State Legislature for 8 years, with roles such as Principal Consultant for the Senate Appropriations Committee and as the Chief Consultant for the State Assembly's Human Services Committee.
She is currently an Assistant Secretary at the California Health & Human Services Agency in the Office of Fiscal and Program Affairs. Additionally, Dr. Cooper serves on the Executive Board of the California Black Health Network.
Gay Grossman is the Co-Founder of ADCY5.org.
Ms. Grossman has been an advocate in the rare disease community for over twenty-five years, advocating for use and access to genetic testing, shared data, and for patients to learn how to use their data. She co-founded ADCY5.org on behalf of her daughter and all those with the rare ADCY5-Movement Disorder Syndrome, to engage directly with researchers and clinicians for novel treatments.
Ms. Grossman previously served as the Director of Patient Advocacy and Engagement at Neurogene, where she helped the organization establish durable and trusting relationships with patients, families, and advocacy groups.
Ms. Grossman has leveraged her personal and professional experience with the pharmaceutical industry to help teach and explain about the burden of disease and educate patients in the fields of genetic testing, biospecimen collection, and rare conditions. This has garnered invitation to speak at numerous university and non-profit venues and recognition from industry leaders such as Biocom California and Illumina.
Dr. Hala Madanat is the Vice President for Research and Innovation at San Diego State University and Albert W. Johnson Distinguished Professor of Public Health. Dr. Madanat stewards the university's expansive research enterprise, leads the development of SDSU's Mission Valley Innovation District, and oversees SDSU's research advancement, support services and technology transfer efforts, the SDSU Research Foundation, as well as the university's start-up incubator, the Zahn Innovation Platform Launchpad.
Under Dr. Madanat's leadership, SDSU's research has grown fiscally, launching accelerator Techstars San Diego Powered by SDSU, developed the Academic Health and Human Services Department, a collaboration between SDSU and the County of San Diego Health and Human Services to establish the Live Well Center for Innovation and Leadership, and launched the CEDR, a recruitment center for underrepresented minorities into clinical trials.
From 2016 to 2020, Dr. Madanat served as the Director of SDSU's School of Public Health. Dr. Madanat is a distinguished professor of health promotion and behavioral sciences. Her research addresses health disparities through community-engaged research. During the COVID-19 pandemic, Dr. Madanat co-led a contact tracing program aimed at enhancing support in underserved communities and curbing the spread of the novel coronavirus.
Dr. Madanat has a B.S. in Biological Sciences from the University of Jordan, a M.S. in Community Health Sciences, and a Ph.D. in Sociology with a minor in Public Health, both from Brigham Young University. Dr. Madanat is also a graduate of the San Diego Chamber of Commerce LEAD Advance program.
Dr. Amy Bernard is Vice President of Science at The Kavli Foundation, where she leads the Foundation's scientific programs in astrophysics, nanoscience, neuroscience, and theoretical physics. With more than 30 years of experience spanning academic research, technology development, and scientific philanthropy, she has helped shape large-scale initiatives and open science programs that have advanced discovery in basic and applied sciences. Prior to joining The Kavli Foundation, Dr. Bernard held a series of leadership roles at the Allen Institute in Seattle. She contributed to creating one of the first large-scale open science platforms in neuroscience - foundational open data resources including the Allen Brain Atlases, Allen Developing Brain Atlases, and Allen Connectivity Atlas - resources that transformed how researchers access and use data in neuroscience.
Dr. Bernard has served on advisory boards and review committees for organizations including the National Institutes of Health, the National Science Foundation, the National Academies of Sciences, Engineering, and Medicine, US BRAIN Initiative and the Chan Zuckerberg Initiative. She has authored more than 80 scientific publications spanning neuroscience, molecular genetics, cell biology, biochemistry, physiology, imaging, and open science. She conducted postdoctoral research on the molecular mechanisms underlying brain growth and development at the University of Washington, and received a Ph.D. in Biophysics and Genetics from the University of Colorado.
Patricia Cooper is the Executive Director of the California Biotechnology Foundation (CBF). CBF is a 501 (c)(3) connecting California policy makers and healthcare stakeholders with the latest healthcare research and data from industry experts and research institutions. Patricia has spearheaded CBF's multiple programs since its founding 20 years ago, advancing life sciences literacy among California's top policy influencers, patients and providers. She is a seasoned coalition builder, directing strategy, expanding partnerships, and leading collaborative campaigns among diverse coalitions from government, state and national coalitions, patient groups, and labor unions. Her engaging campaigns act as templates for international corporations, industry associations and healthcare stakeholders raising the level of literacy and discourse around important life sciences policy.
Prior to CBF, Patricia served as Senior VP of Public Affairs at Weber Shandwick, leading healthcare strategic communications planning and development for clients across the country. She belongs to Wondros Partner Network where she worked on campaigns for the California Endowment, Song for Charlie, and CA Office of Emergency Services. She serves on the Board of Connecting to Cure where they provide IBD patient advocacy, support, community and research funding, the Board of the CA Society for Biomedical Research inspiring young people's interest in life sciences, and on the advisory board for the Rare Disease Access Coalition of California where they strive to make quality care more accessible for every Californian impacted by rare diseases. She is a proud graduate of the University of Oregon.
Dr. Emily Jacobs is a Professor of Psychological and Brain Sciences at UC Santa Barbara and Director of the Ann S. Bowers Women's Brain Health Initiative. Leveraging advancements in precision imaging, AI-driven modeling, and longitudinal deep-phenotyping, Dr. Jacobs' research team is redefining our understanding of the brain's capacity to undergo dynamic neuroanatomical changes and plasticity well into adulthood. In 2024 her team published the first detailed map of the human brain across pregnancy and she leads several multi-center studies on neurological changes tied to menopause. Prior to UCSB, she held a faculty appointment at Harvard Medical School and the Department of Medicine/Division of Women's Health at Brigham & Women's Hospital.
Dr. Jacobs' serves on the Steering Committee of the Coalition for Women's Brain Health, the Milken Institute's Women's Health Network, the Foundation for Women's Health, and the WHAM Research Collaborative to drive the national and international agenda on women's health research. In recognition of her work, Dr. Jacobs was named a Robert Wood Johnson Foundation Health and Society Scholar, a National Institutes of Health BIRCWH Women's Health Fellow, a National Academy of Sciences Frontiers of Science Kavli Fellow and Science News' “Top 10 Scientists” to watch. Outside of the lab, her team partners with K-12 groups to advance girls' representation in STEM. Her work appears in The New York Times, National Geographic, Scientific American, NPR, BBC, TED, Netflix, Radiolab and MasterClass. She is a graduate of Smith College and received her PhD in Neuroscience from UC Berkeley.
Dr. Bishakha Mona is an Advisor at the Science Philanthropy Alliance, where she partners with foundations and philanthropists to shape high-impact science funding strategies across disciplines, with an emphasis in neuroscience. Her work spans research landscape analysis, scientific due diligence, and program development in support of bold, early-stage basic science. She joined the Alliance in 2019 as a neuroscience fellow and has since grown into a strategic role across the philanthropic funding community, contributing thought leadership on open data and data-sharing as drivers of discovery and advocating for greater investment in underfunded areas such as chronic pain.
Bishakha serves as a Board Member of the American Institute of Biological Sciences (AIBS) and an Advisor at Banyan Common. She is committed to mentorship and has supported girls in STEM through the MAGIC mentoring program. Bishakha earned her Ph.D. in Genetics, Development, and Disease from UT Southwestern Medical Center, where her research focused on the molecular mechanisms of spinal cord circuit development. She was honored with both the Dean's Discretionary Award and the Ida M. Green Award, recognizing her research excellence and commitment to advancing women in science. During her Ph.D., she also served as the Science Policy, Education, and Communication Club at UT Southwestern. Bishakha holds an integrated M.Sc. in Biological Sciences with a dual degree in Finance from BITS Pilani, India.
Dr. Sanchez-Vaznaugh is a social epidemiologist and professor in the Department of Public Health, College of Health and Social Sciences at San Francisco State University (SFSU), and affiliated faculty at the Center for Health Equity, UCSF, and the Health Equity Institute (SFSU). Dr. Sanchez-Vaznaugh's research aims to inform program and policy makers in their decisions to improve the health of the public, especially population subgroups with historical social disadvantages. She leads the SoEpi research lab focused on prevention science devoting attention to the social, environmental and policy influences on health and health disparities. Using qualitative and quantitative methods, paired with multiple diverse data sources, her lab's research examines the role of interventions including in communities and school settings as well as local, state and/or federal policies, in preventing disease and promoting health among diverse child and adult populations. The people working in the SoEpi lab strongly value team science, and have built collaborative teams to execute the lab's program of research at SFSU and across other institutions.
Dr. Sanchez-Vaznaugh is currently MPI with Dr. Sánchez (Drexel University) on R01-funded (NICHD and NIMHD) studies to examine population-level influences of policies and community environments on racial/ethnic disparities in childhood obesity and academic performance. Additionally, in collaboration with the Chicago Latino Queer Collaborative, and Dr. Rita Melendez, Professor at SFSU, she is PI of an NIMH-funded quasi-experimental community-based intervention designed to promote sexual health among Latinx gay/bisexual men who have sex with men. Dr. Sanchez-Vaznaugh served on the National Academies of Sciences, Engineering and Medicine (formerly Institute of Medicine) Committee on Physical Activity and Physical Education in the School Environment. She received a Doctorate of Science in Social Epidemiology from Harvard University's School of Public Health, and was a Kellogg's Health Scholar postdoctoral fellow at the Center for Health Equity, UCSF-Berkeley site.
Former Advisors
Dr. Clara Lajonchere is the Deputy Director for the UCLA Institute for Precision Health, Co-Director of the Clinical Neurogenomics Research Center and Adjunct Professor of Neurology in the David Geffen School of Medicine at UCLA. Dr. Lajonchere's background reflects a wide range of professional, clinical, and research activities across central nervous system disorders. She has spent her career on cross-cutting issues in psychiatric genetics and translational medicine. Through the UCLA Institute for Precision Health, Dr. Lajonchere is working collaboratively with thought leaders across the state of California to advance precision medicine and improve outcomes for patients. She currently serves as chair of the California Precision Medicine Advisory Council for the Governor's Office of Planning and Research. Prior to UCLA, Dr. Lajonchere held faculty appointments at the USC Keck School of Medicine where she served as Principal Investigator and Director of the NIH Center for Genomic and Phenomic Studies in Autism and conducted research on models for inclusion of underserved populations in biomedical research. She also served as VP of Clinical Programs for Autism Speaks for over a decade where she oversaw a diverse portfolio of basic science and clinical programs. She currently consults for several tech start-ups in the autism space focused on AI, robotics, and targeted therapeutics.
Dr. Keith R. Yamamoto is Vice Chancellor for Science Policy and Strategy, and Director of Precision Medicine at UCSF. A UCSF researcher since 1973, he is a leader in determination of gene regulatory mechanisms. He has led or served on national committees focused on public and scientific policy, public understanding of science, science education, open science, and peer review. He chairs the Coalition for the Life Sciences and sits on the National Research Council Governing Board Executive Committee, the Board of Directors of Research!America, the Board of Directors of the Public Library of Science, the Governing Board of the California Institute for Regenerative Medicine, and the Advisory Board for Lawrence Berkeley National Laboratory. As Chair of the National Academy of Sciences Board on Life Sciences, Dr. Yamamoto created the study committee that produced Toward Precision Medicine, which enunciated the precision medicine concept, and he helped lead efforts in the White House, Congress, Sacramento, and UCSF to implement it. He was elected to the National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences, and is a fellow of the American Association for the Advancement of Science.
Dr. Kenneth Kim received his MD from Harvard Medical School, completed a fellowship at the MIT Sloan School of Management, and received internal medicine and allergy/immunology training at UCLA. He has served on the clinical faculty both at UCLA and UC Irvine for over 15 years. He has been a medical monitor, consultant, and investigator on over 600 clinical trials, having published over 30 research articles and 50 abstracts in peer-reviewed journals. He is a nationally recognized expert in the areas of early stage clinical research, ethnobridging drug development strategy, influenza challenge, mold allergy, and latex allergy.
He has founded numerous health care services businesses, including a 200+ employee clinical research organization which he transitioned to private equity. He is currently the medical director of Ark Clinical Research and a strategic investor in a variety of startups, while also maintaining a private allergy and asthma practice in Southern California.
Dr. Fatima Muñoz is the Director of the Department of Research and Health Promotion at San Ysidro Health (SYHealth), a high performing Federally Qualified Health Center (FQHC) providing care to over 105,000 patients throughout San Diego County. Fatima completed her medical training in Mexico and earned a Master's in Public Health from Universidad Autónoma de Baja California. She possesses over 15 years of clinical research experience working in health promotion programs and epidemiological research studies, specifically among underserved populations. Fatima's expertise in public health issues spans both sides of the U.S.-Mexico border with emphasis in the elimination of health disparities. Her award winning research portfolio includes: chronic disease, HIV prevention and treatment, cervical and breast cancer, and the impact of bi-national access to care on health policy. Most recently, SYHealth was awarded the All of Us Research Program from the National Institute of Health. It is only one of six FQHCs west of the Mississippi that is part of this Program and Fatima is the Principal Investigator for SYHealth. In this capacity, she and her team have been contributing in the development and implementation of the program Spanish speaking participants.
As former VP and Head of Diagnostics, Dr. Hakan Sakul founded and led Pfizer's Diagnostics group, with dozens of drug/diagnostics combination approvals in global markets under his leadership. During his 24-year tenure at Pfizer, Hakan also held leadership positions in Clinical Pharmacogenomics, Molecular Profiling, and Translational Oncology. One of his most significant professional accomplishments was to lead Pfizer's flagship CDx program for Xalkori®, resulting in simultaneous FDA approvals of the drug/diagnostic combination in 2011. Prior to Pfizer, Hakan worked in the biotech industry in human genetics and statistical genetics. Hakan's contributions to precision medicine and diagnostics have been widely recognized through both internal and external awards and frequent speaking engagements. He is a former member of the Board of The Personalized Medicine Coalition, served as a Scientific Advisory to Luminex Corp, and currently is a Board member of Progentec Diagnostics, as well as BASH Biotech. Hakan is a member of California Gov Newsom's Precision Medicine Advisory Council. He received his BS and MSc degrees from Ankara University in Turkey, PhD in Quantitative Genetics from the University of Minnesota as a Rotary Foundation Scholar and conducted postdoctoral studies at the University of California-Davis. He has authored over 30 refereed scientific articles as well as many other publications. Hakan is keenly interested in molecular diagnostics, liquid biopsy and related medical technologies to advance Precision Medicine for the improvement of individualized healthcare.
Corrin Buchanan serves as the Deputy Secretary for Policy and Strategic Planning at the California Health & Human Services Agency.
Corrin has spent most of her career in systems change work in state and local government. Prior to joining CalHHS, Corrin served at the Assistant Director of Housing and Homelessness for the California Department of Social Services. She worked for the Los Angeles County Department of Health Services as the Deputy Director for the Office of Diversion and Reentry where she oversaw countywide behavioral health diversion, reentry, and youth diversion and development efforts. Also with Los Angeles County Department of Health Services, she launched and managed the Flexible Housing Subsidy Pool, a locally funded rental subsidy program with the Housing for Health division. Corrin was Health Program Planner for Housing and Urban Health at the San Francisco Department of Public Health and the Community Programs Director for the San Francisco Women's Building. Corrin holds a Bachelor's degree and a Master's degree in Public Policy from UC Berkeley.
Dr. Devika Bhushan is an equity-focused pediatrician and public health practitioner who serves as California's Former Surgeon General, who focussed on three key cross-sector priorities: Adverse Childhood Experiences (ACEs) and toxic stress, early childhood development, and health equity. Previously, Dr. Bhushan served as the inaugural Chief Health Officer of the Office of the California Surgeon General.
Ysabel Duron is the Founder/CEO of the California based Latino Cancer Institute working to eliminate the Latino cancer burden nationwide by driving equitable access, research and policy.
Duron was an award-winning TV journalist for 43 years in the San Francisco Bay Area and elsewhere, but stepped away in 2013 to continue her role as a patient advocate and voice for the Latino community.
A cancer survivor, she serves both on the Institutional Review Board of the NIH All of Us Research Program, and most recently joined the Board of California Institute for Regenerative Medicine, a state taxpayer funded initiative to support stem cell research.
She was inducted into the National Association of Hispanic Journalists Hall of Fame in 2009, named one of the 25 most outstanding Hispanics in the Bay Area in 2005 and honored with the W.E.B. DuBois from the SJ Chapter of the NAACP in 2011, amongst other honors that reflect her community engagement.
Dr. Nadine Burke Harris is an award-winning physician, researcher and advocate dedicated to changing the way our society responds to one of the most serious, expensive and widespread public health crises of our time: childhood trauma. She was appointed as California's first-ever Surgeon General by Governor Gavin Newsom in January 2019. Her career has been dedicated to serving vulnerable communities and combating the root causes of health disparities. Dr. Burke Harris founded the Center for Youth Wellness in one of San Francisco's most underserved communities, Bayview-Hunters Point, an organization leading the effort to advance pediatric medicine, raise public awareness, and transform the way society responds to children exposed to Adverse Childhood Experiences (ACEs) and toxic stress. She also founded and led the Bay Area Research Consortium on Toxic Stress and Health, to advance scientific screening and treatment of toxic stress.
Dr. K. Jones (they/them) is the Assistant Secretary of Programs and Fiscal Affairs at the California Health & Human Services Agency.
They received their PhD in Interdisciplinary Neuroscience from the University of Missouri and a BS in Psychology from The Ohio State University.
As a postdoctoral research fellow at UC Davis, they were a leader in the field of autism research, specializing in identifying genetic and environmental risk factors of autism spectrum disorder to move toward precision medicine. They have additional expertise in psychology, neuroimmunology, nutrition, and epidemiology. Dr. Jones has participated in consortiums that resolve science, clinical practice, and policy issues related to autism. They have contributed high-profile scientific manuscripts to the American Association for the Advancement of Science.
After their postdoctoral work, Dr. Jones was selected to be a Society for Neuroscience Policy Ambassador and advocated for voters' rights and social justice issues as the inaugural Trudy Schafer Advocacy Fellow at the League of Women Voters of California. Prior to joining CalHHS, they served as Legislative Director to Assemblymember Dr. Joaquin Arambula.
Dr. Oliver Keown is a UK-trained physician, scientist and former policy advisor turned healthcare and medical technologies venture capital investor with Intuitive Ventures. Prior to joining Intuitive, he was a VC investor with GE Ventures, driving startup deal-flow in the Bay Area and beyond across HealthTech, life science and MedTech domains.
In past roles Oliver has advised and supported a range of US and international healthcare innovation projects across technology, policy, commercial, and academic fields. Early in his career he worked as a junior doctor in the UK National Healthcare Service across a variety of medical and surgical disciplines. He holds an MD and a Bachelor's degree in Pharmacology from the University of Edinburgh, Scotland.
Dr. Yvonne (Bonnie) A. Maldonado is Professor in the Departments of Pediatrics and Epidemiology and Population Health, Chief of the Division of Infectious Diseases, and Senior Associate Dean for Faculty Development and Diversity at Stanford University School of Medicine. Her research activities have included the epidemiology and prevention of viral infections such as rotavirus, measles, mumps, rubella, polio and pediatric HIV infection. Her research is conducted internationally in Zimbabwe and Mexico, as well as in the United States. She has written over 200 articles in peer-reviewed journals, and 50 book chapters on these topics. In 1989, Dr. Maldonado received the Epidemic Intelligence Service Alumni Award from the Centers for Disease Control and Prevention, and she was inducted into the Multicultural Alumni Hall of Fame at Stanford University in 2001 and the Stanford Medical Alumni RISE (Reach, Inspire, Serve and Engage) award in 2018. She is a Fellow of the American Academy of Pediatrics, a member of the Society for Pediatric Research, the Pediatric Infectious Disease Society and the American Public Health Association. Dr. Maldonado has devoted substantial effort to teaching and training activities at Stanford University as well as in the national and international setting. Throughout her career, she has invested heavily in her commitment to improving cultural and gender diversity at all levels.
Dr. Samar Muzaffar is an assistant secretary at the California Health and Human Services Agency. Prior to her appointment she was a population health and health systems design consultant for Integrated Health Solutions LLC. Dr. Muzaffar previously served as chief medical officer at the Missouri Department of Social Services for Missouri's Medicaid program and was the Emergency Medical Services medical director at the Missouri Department of Health and Senior Services. She served as an adjunct instructor at Washington University's Brown School, and was a clinical instructor and clinical assistant professor at the University of Missouri - Columbia University Hospital. Dr. Muzaffar is a member of the American College of Preventive Medicine's Board of Regents and Health Systems Transformation Task Force, and the American Academy of Pediatrics Institute for Healthy Childhood Weight TEAM UP Payer Advisory Board. She earned a Master of Public Health degree from Johns Hopkins University and a Doctor of Medicine degree from the University of Missouri-Columbia School of Medicine.
Dr. Mary Anne Schultz is an accomplished Senior Executive and Consultant with more than 40 years of success across the nursing service, nursing education, informatics, and clinical/business intel venues. Her broad areas of expertise include data analysis, program evaluation, and evidence-based practices customized to a system's health care client. Throughout her executive career, Mary Anne has held faculty and leadership positions within the California State University and University of California systems, and $chultz & Associates. Dr. Schultz is a Professor, Informaticist and former Chair for the Nursing Department at California State University, San Bernardino. She holds a PhD in Nursing Systems and Economics from UCLA, an MBA from Claremont Graduate University, and a certificate in Health Informatics from UC Davis.